Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) and Secondary Central Nervous System (sCNS) Involvement from the Center for International Blood and Marrow Transplant Research (CIBMTR) RegistrySairah Ahmed, Jennifer L. Crombie, Soyoung Kim et al.|Blood|2024Cited by 6
Outcomes of Standard of Care (SOC) Lisocabtagene Maraleucel (liso-cel) in Patients (Pts) with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) and Secondary CNS (sCNS) Involvement from the Center for International Blood and Marrow Transplant Research (CIBMTR) RegistrySairah Ahmed, Jennifer L. Crombie, Avyakta Kallam et al.|Transplantation and Cellular Therapy|2025Cited by 2
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphomaJennifer L. Crombie, Iris Isufi, Sairah Ahmed et al.|Blood|2026Cited by 1